| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 3 securities · may seek to influence control | ||||||
|
Yarrow Bioscience, Inc.
13D/A
YARW · 92941V407
|
6.0% |
7/29/2026
Event 7/27/2026
|
||||
| AI Biotechnology LLC | 6.0% | |||||
| Access Industries Holdings LLC | 6.0% | |||||
| Access Industries Management, LLC | 6.0% | |||||
| Len Blavatnik | 6.0% | |||||
|
OnKure Therapeutics, Inc.
13D
OKUR · 68277Q105
|
20.0% |
4/7/2026
Event 3/31/2026
|
||||
| AI Biotechnology LLC | 20.0% | |||||
| Access Industries Holdings LLC | 20.0% | |||||
| Access Industries Management, LLC | 20.0% | |||||
| Len Blavatnik | 20.0% | |||||
|
Zura Bio Limited
13D/A
ZURA · G9TY5A101
|
18.2% |
3/2/2026
Event 2/26/2026
|
||||
| AI Biotechnology LLC | 18.2% | |||||
| Access Industries Holdings LLC | 18.2% | |||||
| Access Industries Management, LLC | 18.2% | |||||
| Len Blavatnik | 18.2% | |||||
| Schedule 13G · 2 securities · passive | ||||||
|
Latigo Biotherapeutics, Inc.
13G/A
LTGO · 517954103
|
4.8% |
11/6/2026
Event 9/3/2026
|
||||
| AI Biotechnology LLC | 4.8% | |||||
| Access Industries Holdings LLC | 4.8% | |||||
| Access Industries Management, LLC | 4.8% | |||||
| Len Blavatnik | 4.8% | |||||
|
Surrozen, Inc.
13G
SRZN · 86889P208
|
9.9% |
3/31/2025
Event 3/24/2025
|
||||
| AI Biotechnology LLC | 9.9% | |||||
| Access Industries Holdings LLC | 9.9% | |||||
| Access Industries Management, LLC | 9.9% | |||||
| Len Blavatnik | 9.9% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.